The proposed OMB changes to research funding threaten US science. Researchers must stand up for and share the value of ...
NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...
Perovskite silicon tandem solar cell efficiency now has an accredited European calibration pathway: Germany’s ISFH CalTec ...
Consumer Reports’ latest food safety investigation found some rice products contain concerning levels of a harmful heavy ...
Spread the love“`html In the fast-paced world of scientific research and academia, the importance of proper documentation ...
Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) and Omega Laboratories, ...
(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its second quarter 2026 financial results after the close of U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results